Posted by Maddie Sorensen on May 11th, 2024
Xencor (NASDAQ:XNCR – Get Free Report) released its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.28),...
More of this article »